OSSIO
Brian Verrier is the Chief Executive Officer of OSSIO, Ltd., a company focused on transforming orthopedic fixation with innovative, biologically friendly materials since March 2017. Prior to this role, Brian served as President of Worldwide Peripheral Vascular Businesses at Medtronic from March 2010 to June 2016, overseeing key areas such as arterial and venous health, DVT prevention, and dialysis access. Brian's experience also includes a position as Global VP & GM of Vascular Therapies at COVIDIEN LP and VP of US Sales at Medtronic Vascular. Brian holds a Bachelor's degree in Economics from the University of Connecticut, earned between 1986 and 1990.
OSSIO
OSSIO is an orthopedic fixation company committed to transforming the orthopedic experience for patients, physicians, and payors. Their vision is to provide the first credible replacement to metal implants in the $10B+ orthopedic fixation market (screws, pins, plates) with an Intelligent Bone Regeneration Technology. OSSIOfiber represents abreakthrough material platform for orthopedic and podiatric surgeons who seek a more biologically friendly way to restore patient stability and mobility with nothing permanent left behind.Founded in 2014, OSSIO began as the culmination of years of biomechanical research and a vision for the possibility of better bone healing. The technological basis of OSSIOfiber™ was developed and would lay the groundwork for ushering in a new breakthrough category of non-permanent fixation, “Bio-Integratives” hardware that has both desired strength AND bio-friendliness. Hardware that has the mechanical strength for easy insertion and secure fixation, while enabling the body to regrow bone, incorporating and replacing the implant (without the adverse inflammation and weakness often seen in “bio-resorbables and other “bio-composites”), has remained elusive to the industry until now.